|AHFS/Drugs.com||International Drug Names|
|ATC code||G03GB01 (WHO)|
|Chemical and physical data|
|Molar mass||364.434 g/mol|
|3D model (Jmol)||Interactive image|
Cyclofenil (INN, USAN, BAN) (brand names Fertodur, Ondonid, Ondogyne, Sexovid, and others) is a selective estrogen receptor modulator used as a gonadotropin stimulant which is marketed in Europe, South Korea, Mexico, and Brazil, among other countries.
Cyclofenil was studied in the 1970s as an agent to induce ovulation in infertile women. It was then investigated as a possible treatment for scleroderma in the 1980s, but was found to be ineffective. Later study of its efficacy in treating Raynaud's phenomenon in people with scleroderma also found no statistically significant benefit.
- Index Nominum 2000: International Drug Directory. Taylor & Francis. January 2000. pp. 284–. ISBN 978-3-88763-075-1.
- J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 329–. ISBN 978-1-4757-2085-3.
- Ruíz-Velasco V, Rosas-Arceo J, Matute MM. "Chemical inducers of ovulation: comparative results". Int J Fertil. 1979;24(1):61-4. PMID 37182.
- Torres MA, Furst DE (February 1990). "Treatment of generalized systemic sclerosis". Rheum Dis Clin North Am. 16 (1): 217–41. PMID 2406809.
- Pope J, Fenlon D, Thompson A, et al. (2000). Pope J, ed. "Cyclofenil for Raynaud's phenomenon in progressive systemic sclerosis". Cochrane Database Syst Rev (2): CD000955. doi:10.1002/14651858.CD000955. PMID 10796397.